Back to Cubist Systematic Strategies, LLC Cubist Systematic Strategies, LLC

KNTEKNTE
10 quarters

Position history for Cubist Systematic Strategies, LLCCubist Systematic Strategies, LLC's holdings in KINNATE BIOPHARMA INC

Cubist Systematic Strategies, LLC previously held 0 shares of KNTE (KINNATE BIOPHARMA INC), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$169,000

Total Shares Change

-7,361

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q1
Decreased
4,102
-67.3%
$10,9110.0%
0
2023-Q4
Decreased
12,527
-71.3%
$29,6890.0%
0
2023-Q3
Decreased
43,716
-60.6%
$61,2020.0%
0
2023-Q2
New
110,912
-
$336,0630.0%
33
2023-Q1
Exited
0
-100.0%
$00.0%
0
2022-Q4
Increased
18,386
+78.3%
$112,1550.0%
33
2022-Q3
New
10,315
-
$123,0000.0%
31
2021-Q4
Exited
0
-100.0%
$00.0%
0
2021-Q3
New
7,361
-
$169,0000.0%
31

Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used